Home
Partner With Us
Contact
News Investors Blog
Contact us
Learn More About Atomo
Company
About Us
Vision, Mission & Values
Governance
Our People
Leadership & Board
Work With Us
Learn More About Our Products
Products on the Market
HIV 1&2 Tests
Pregnancy Test
Respiratory Test
Learn More About Our Technology
Platforms
AtomoRapid Pascal
Atomo Swab Platform
AtomoRapid Galileo
AtomoRapid Elion
AtomoRapid Fleming
AtomoRapid Franklin
Partnering with Atomo
Partnerships
Device development pathway*
Our partners
Case studies
Expertise
Medical device design*
Original equipment manufacturing (OEM)*
Solutions
Self testing*
Telehealth*
Data connectivity*
eHealth*
Wellness industry*
Light grey background with one-third of the Atomo circle in dark grey on the right hand side and a series of dark grey dots in the top right-hand corner

News

Empowering people to enjoy healthier, more informed lives through fast, accurate point-of-care testing.

‘HIV no barrier to a full life’
February 13, 2023
Women living with HIV in Australia continue to face stigmatisation
February 13, 2023
‘HIV doesn’t discriminate, everyone should get tested’
February 13, 2023
HIV self-test funds ‘a vital step in eradication’
January 25, 2023
Atomo, NG Biotech Partner on Blood-Based Pregnancy Test
January 18, 2023
Atomo Diagnostics to showcase range at Arab Health
January 16, 2023
STIs in Australia are down, but fewer tests could be the cause
December 08, 2022
Call to bring HIV testing rates back to pre-pandemic levels
December 01, 2022
Budget lays strong foundations for LGBTIQ health and steps up HIV effort
October 27, 2022
UNAIDS and partners convene emergency meeting
October 11, 2022
Two Australian organisations share in more than $1m
August 29, 2022
The rise of home diagnostics and proactive self-care
August 15, 2022
Canada is making HIV testing more accessible
August 02, 2022
Shock HIV boom in Australia’s backyard prompt calls to do more
August 01, 2022
Home-based tests boost fight against HIV
July 19, 2022
Why At-Home HIV Testing Could be a Game Changer
July 15, 2022
AFAO’s O’Donnell on Australia’s Campaign to End HIV Transmission
July 05, 2022
Is Biotech Headed for Bear Run?
July 05, 2022
Wales plan to end new HIV cases includes easier PrEP and condom access
June 15, 2022
World must ‘speed up’ efforts to end AIDS pandemic by 2030
June 15, 2022
Access to self-testing is one of the pillars of Australia’s HIV prevention strategy.
June 09, 2022
Atomo Diagnostics Limited Expands Executive Team
June 03, 2022
Get tested in HIV Testing Week
June 02, 2022
NSW HIV cases drop, but testing also low
June 02, 2022
Education for pharmacists on HIV self-testing
March 31, 2022
COVID-19 sparks at-home HIV test revolution
November 02, 2021
Equity ASA Podcast – John Kelly
September 20, 2021
Atomo Diagnostics (ASX:AT1) and Viatris to Support HIV Self-Test Supply
April 29, 2021
Experts call for TGA-approved rapid COVID-19 tests to be used in Australia
March 22, 2021
Escrow: Here’s why it’s worth watching and which stocks are releasing shares soon
March 11, 2021
Is Atomo Diagnostics Finally Ready to Take Off?
March 09, 2021
The Atomo Diagnostics share price is popping 7% today
March 02, 2021
Atomo gains rights to rapid antigen test
October 01, 2020
“Game changing” deal for Aussie biotech Atomo
September 30, 2020
Why the Atomo (ASX:AT1) share price is moving higher today
September 29, 2020
Prev
Next
Smiling woman leaning on the back of a smiling man in an outdoor setting with trees in the background

Re-imagining diagnostics.

Get in touch